Regression of a spinal schwannoma after Pomalidomide (2020)

Type of publication:
Journal article

Author(s):
Kunnel Jomon M.; Pepper J.; Price R.; *O’Connor N.

Citation:
British Journal of Neurosurgery; Mar 2020 ; p. 1-2

Abstract:
A 77-year old female with a history of neurofibromatosis type 2 (NF2) was diagnosed with a spinal schwannoma that was managed conservatively over a decade. During this time, follow up imaging revealed this lesion had been growing and the patient had become symptomatic from it necessitating surgical decompression. However, the patient had been diagnosed with multiple myeloma and underwent treatment with Pomalidomide chemotherapy which delayed surgery for the spinal schwannoma. Further imaging of the spine revealed significant regression in the size of the spinal schwannoma. This phenomenon has not previously been reported and this report aims to explore the implications of Pomalidomide in patients with NF2 related spinal schwannomas.

Altmetrics: